The United States Department of Justice (DOJ) recently announced that Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. will pay $450 million to resolve allegations of violating the ...
A coalition of state attorneys general, including those in Pennsylvania and New Jersey, has reached agreements with two ...
State attorneys general have reached a settlement over price-fixing by generic drugmakers for the first time since they began probing the issue a decade ago.
On October 31, 2024, the European Commission issued a fine of €462.6 million to Teva Pharmaceuticals, citing abuse of its ...
Some two years after the European Commission accused Teva of meddling with the competition for its former multiple sclerosis blockbuster Copaxone, the other shoe has finally dropped. | The European ...
The settlement resolves allegations that the company engaged in widespread ... The second complaint was filed in 2019 against Teva Pharmaceuticals and 19 of the nation’s largest generic drug ...
Last year, Teva was ordered to pay $225 million to settle price fixing charges in the U.S. related to sales of a cholesterol-lowering drug. The U.S. Justice Department said the agreement also required ...
Two pharmaceutical companies will pay $49.1 million to resolve allegations of widespread ... have since entered into ...
Attorney General Todd Rokita, as part of a coalition of 46 states and four territories, has secured $49.1 million in settlements to resolve allegations that two companies engaged in widespread, ...